Related Experiment Video

Updated: Aug 19, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

[Oncogenes and thyroid tumors]

Ludovic Lacroix1, Jean Charles Soria, Jean Michel Bidart

  • 1Institut Gustave-Roussy, 94805 Villejuif Cedex.

Bulletin Du Cancer
|February 4, 2005
PubMed

Insights

Genetic mutations in thyroid cancer are common. Papillary thyroid carcinomas often have RET/PTC rearrangements or BRAF/RAS mutations, while follicular carcinomas show RAS mutations or PAX8-PPARgamma rearrangements. Anaplastic thyroid carcinomas feature p53 gene mutations.

Area of Science:

  • Oncology
  • Genetics
  • Endocrinology

Background:

  • Thyroid carcinomas are the most common endocrine malignancies.
  • Understanding the genetic drivers of different thyroid carcinoma subtypes is crucial for diagnosis and treatment.
  • Specific genetic alterations are associated with distinct histological types of thyroid cancer.

Purpose of the Study:

  • To identify and characterize the key genetic alterations present in major thyroid carcinoma subtypes.
  • To correlate specific gene mutations and rearrangements with papillary, follicular, and anaplastic thyroid carcinomas.
  • To elucidate the role of genetic mutations in the pathogenesis of thyroid cancer.

Main Methods:

  • Analysis of genetic mutations and rearrangements in thyroid carcinoma tissues.
  • Utilizing molecular techniques to detect specific gene alterations (e.g., RET/PTC, RAS, BRAF, PAX8-PPARgamma, p53).
  • Correlation of molecular findings with histopathological classification of thyroid tumors.

Main Results:

  • Papillary thyroid carcinomas (70% of cases) exhibit RET/PTC rearrangements or activating mutations in BRAF or RAS genes, leading to MAP kinase pathway activation.
  • Follicular carcinomas are associated with RAS mutations or PAX8-PPARgamma rearrangements.
  • Inactivating mutations of the p53 gene are exclusively identified in anaplastic thyroid carcinomas.

Conclusions:

  • Distinct genetic profiles characterize different subtypes of thyroid carcinoma.
  • Specific molecular alterations serve as diagnostic markers for papillary, follicular, and anaplastic thyroid cancers.
  • Targeting specific pathways activated by these mutations may offer therapeutic strategies for thyroid cancer.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...